Aerpio Pharmaceuticals, Inc.·4

Nov 6, 4:15 PM ET

Marek Regina 4

4 · Aerpio Pharmaceuticals, Inc. · Filed Nov 6, 2019

Insider Transaction Report

Form 4
Period: 2019-11-04
Marek Regina
Vice President of Finance
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-11-04+44,30044,300 total
    Exercise: $0.56Exp: 2029-11-04Common Stock (44,300 underlying)
Footnotes (1)
  • [F1]Options exercisable as to 1/4th on February 15, 2020 and an additional 1/48th monthly thereafter until February 15, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION